Cannabis and Sleep: Effects, Risks, and Alternatives

Sleep disorders are among the most common health problems in industrialized countries – an estimated 30 to 35 percent of the adult population suffers from occasional, and 10 to 15 percent from chronic sleep disturbances. Cannabis is increasingly used as a sleep aid, both in medical contexts and through self-medication. Yet the relationship between cannabis and sleep is complex and by no means as unequivocally positive as popular portrayals suggest. This article examines the effects of different cannabinoids on sleep, analyzes risks such as tolerance development and rebound insomnia, and presents evidence-based alternatives.

## Sleep Architecture: The Basics

Understanding the effects of cannabis on sleep requires knowledge of normal sleep architecture. Human sleep proceeds in cycles of 90 to 110 minutes each, repeating four to five times throughout the night. Each cycle consists of several stages:

### Non-REM Sleep

Non-REM sleep (NREM) is divided into three stages. Stage N1 is light sleep at sleep onset, lasting only a few minutes. Stage N2 is the stable sleep phase, accounting for approximately 50 percent of total sleep time, characterized by typical EEG patterns such as sleep spindles and K-complexes. Stage N3, also known as deep sleep or slow-wave sleep (SWS), is the most restorative sleep phase, during which growth hormones are released, tissue repair occurs, and the immune system is strengthened. Deep sleep dominates the first half of the night.

### REM Sleep

REM sleep (Rapid Eye Movement) is the dream sleep phase. It is characterized by rapid eye movements, muscle atonia (skeletal muscle paralysis), and vivid dreams. REM sleep is essential for emotional processing, memory consolidation, and cognitive recovery. REM phases become longer throughout the night and dominate the second half.

## THC and Sleep

THC is the most commonly used cannabinoid as a sleep aid. Its effects on sleep are dose-dependent, biphasic, and change with duration of use.

### Acute Effects on Sleep Onset

THC significantly reduces sleep onset latency (the time from going to bed to falling asleep). Several controlled studies show a reduction in sleep onset time of 15 to 30 minutes at doses of 10 to 20 mg THC. This effect is mediated via CB1 receptors in the hypothalamus and brainstem that influence circadian rhythm and wakefulness regulation. THC increases adenosine levels in the basal forebrain, partly explaining its sleep-promoting effect. Adenosine accumulates during wakefulness and produces drowsiness – THC accelerates this process.

### Effects on Sleep Architecture

THC's effects on sleep architecture are complex and not uniformly positive.

**Deep Sleep (N3):** THC can increase the proportion of deep sleep in acute use. This is often perceived as more restful sleep and is one of the reasons THC is valued as a sleep aid. However, the increase in deep sleep is not consistent across all studies and appears to be dose-dependent.

**REM Sleep Suppression:** THC suppresses REM sleep significantly. With regular use, the REM proportion can decrease from the normal 20–25 percent to 10–15 percent or less. This REM suppression has far-reaching consequences. In the short term, it leads to fewer dreams, which can be therapeutically useful in PTSD patients with distressing nightmares. In the long term, however, chronic REM suppression can impair emotional processing, learning, and cognitive regeneration.

**Sleep Continuity:** THC reduces the number of nocturnal awakenings and extends total sleep time. Patients frequently report "sleeping through" – an effect particularly valued by chronic pain patients, as pain frequently leads to fragmented sleep.

### Dose-Dependent Effects

THC's effects on sleep are strongly dose-dependent and show a biphasic pattern. Low doses (2.5–5 mg THC) promote sleep without greatly altering sleep architecture. Moderate doses (10–20 mg THC) markedly reduce sleep onset time, increase deep sleep, and suppress REM sleep. High doses (above 20 mg THC) can paradoxically worsen sleep quality, as they may trigger anxiety, tachycardia, and restlessness that hinder falling asleep.

## CBD and Sleep

CBD has a different effect profile on sleep than THC and also shows dose-dependent, sometimes paradoxical effects.

### Low Doses: Wakefulness-Promoting

At low doses (below 50 mg), CBD tends to promote wakefulness. CBD inhibits adenosine reuptake, which can paradoxically promote short-term alertness. It also interacts with serotonin receptors (5-HT1A) involved in sleep-wake regulation. This wakefulness-promoting effect makes low-dose CBD suitable for daytime use, not as a sleep aid.

### Higher Doses: Sleep-Promoting

At higher doses (100–300 mg), CBD shows sleep-promoting properties. A Brazilian study (Zuardi et al., 2017) found that 300 mg CBD improved sleep quality in subjects with insomnia. The mechanism is likely multifactorial: anxiolysis (anxiety reduction) via 5-HT1A, facilitating sleep onset in anxiety-related insomnia; muscle relaxation reducing physical tension; and pain reduction helping with secondary insomnia from chronic pain.

### CBD for Anxiety-Related Insomnia

The likely greatest benefit of CBD for sleep lies in its anxiolytic effect. Many sleep disorders are secondary to anxiety disorders – rumination, worry, and an overactive nervous system prevent falling asleep. CBD reduces amygdala activity and lowers cortisol levels, which can facilitate sleep onset in anxiety-related insomnia. A case series by Shannon et al. (2019) showed that 72 percent of anxiety patients receiving CBD therapy (25–175 mg) reported improved sleep quality in the first month.

## CBN: The "Sleep Cannabinoid"?

Cannabinol (CBN) is frequently marketed as the "sleep cannabinoid," but the scientific evidence for this claim is surprisingly thin.

### Origin and Properties

CBN is formed through the oxidative degradation of THC. As cannabis ages and THC degrades through light, air, and heat, it is partially converted to CBN. CBN binds weakly to CB1 receptors (approximately one-tenth the affinity of THC) and has low psychoactive potency.

### The Evidence Question

The claim that CBN is sedating is largely based on anecdotal reports and a single study from the 1970s (Musty et al., 1976) that had methodological flaws. The sedating effect of aged cannabis, often attributed to CBN, could equally be due to increased concentrations of sedating terpenes such as myrcene and linalool released during the degradation of other compounds. More recent studies are contradictory: some find mild sedating effects of CBN in combination with THC, while others find no significant effect of CBN alone on sleep. A promising aspect of CBN is its possible muscle relaxant effect, which could indirectly contribute to improved sleep.

## Terpenes and Sleep

Terpenes – the aromatic compounds in cannabis – are increasingly being studied as independent sleep-promoting substances.

### Myrcene

Myrcene is the most common terpene in cannabis and is known for its sedating and muscle-relaxing properties. Animal studies show that myrcene extends sleep duration and acts as a muscle relaxant. Indica-dominant cultivars with high myrcene content are traditionally recommended as "nighttime strains." The sedating effect of myrcene is mediated through GABAergic mechanisms, similar to benzodiazepines but significantly weaker.

### Linalool

Linalool, also found in lavender, has demonstrated anxiolytic and sedating properties. Inhaled linalool reduces sympathetic nervous system activity and lowers cortisol levels. The combination of linalool with CBD can produce synergistic anxiolytic effects that facilitate sleep onset.

### Beta-Caryophyllene

Beta-caryophyllene is a terpene with CB2 agonism. It has anti-inflammatory and analgesic properties that can be useful for secondary insomnia caused by chronic pain. It does not directly promote sleep but can improve sleep quality by addressing pain-related causes of sleep disturbance.

## Tolerance Development

One of the biggest problems with using THC as a sleep aid is tolerance development.

### Mechanism

With regular THC exposure, CB1 receptors internalize and desensitize – they are relocated from the cell surface into the cell interior and become less sensitive to stimulation. This process begins within just a few days of regular use. After two to four weeks of daily use, many users report that the sleep-promoting effect diminishes and they need to increase the dose to achieve the same effect. This tolerance-dose-escalation cycle can become problematic.

### Countermeasures

To counteract tolerance development, experts recommend using the lowest effective dose, taking regular "tolerance breaks" (e.g., two to three days per week without cannabis), rotating between different cannabis products with varying cannabinoid and terpene profiles, and supplementing with CBD, which may modulate CB1 tolerance.

## Rebound Insomnia

Rebound insomnia is one of the most significant risks of chronic THC use as a sleep aid.

### What Happens Upon Discontinuation?

When a regular THC user abruptly stops, a "REM rebound" typically occurs – a strong increase in REM sleep caused by the preceding suppression. This manifests as intense, vivid, and often unpleasant dreams; prolonged sleep onset time; frequent nocturnal awakenings; and overall worsened sleep quality. Rebound insomnia typically begins one to three days after discontinuation and can last two to six weeks – in some cases even longer. The intensity correlates with the duration and level of preceding THC exposure.

### Tapering Instead of Abrupt Cessation

To minimize rebound insomnia, gradual tapering is recommended: reducing the THC dose by 10–25 percent every three to five days over a period of two to four weeks. CBD can be used concurrently to alleviate withdrawal symptoms. Sleep hygiene measures and, if necessary, short-term conventional sleep aids can ease the transition period.

## Cannabis vs. Conventional Sleep Medications

### Benzodiazepines and Z-Drugs

Compared to benzodiazepines (diazepam, lorazepam) and Z-drugs (zolpidem, zopiclone), cannabis has some potential advantages: lower risk of fatal overdose, less fall risk in elderly patients, and potentially lower physical dependence potential. However, the evidence base for cannabis as a sleep aid is considerably smaller than for established hypnotics, and sleep architecture alterations (REM suppression) are more pronounced with THC than with many Z-drugs.

### Melatonin

Melatonin regulates the circadian rhythm and has a favorable side effect profile. It can be combined with cannabis with no known interactions. For pure sleep onset problems, melatonin (0.5–3 mg) is often sufficient and should be considered as a first-line option before cannabis.

### Cognitive Behavioral Therapy for Insomnia (CBT-I)

CBT-I is considered the gold standard for insomnia treatment and shows sustained effects without medication side effects. In clinical practice, cannabis can be used as bridge therapy while CBT-I is being established, with the goal of eventually tapering cannabis.

## Practical Recommendations

### When to Consider Cannabis as a Sleep Aid?

Cannabis as a sleep aid should be considered for secondary insomnia due to chronic pain (where cannabis addresses two problems simultaneously), for PTSD-associated nightmares (short-term REM suppression can be therapeutically useful), when conventional sleep therapies have failed, and in patients already receiving cannabis for other indications.

### Optimal Delivery for Sleep

For sleep, the following approaches are suitable: oral administration (dronabinol drops, edibles) offers longer duration of six to eight hours, better addressing sleep maintenance problems, but requires intake 60–90 minutes before bedtime. Vaporization provides rapid onset (5–15 minutes), advantageous for sleep onset issues, but shorter duration of two to four hours. Sublingual drops offer medium onset (15–45 minutes) and medium duration (four to six hours).

### Strain Selection

For sleep, THC-dominant or balanced strains with high myrcene content are typically recommended. Bedica (THC approximately 14%, myrcene-dominant) and similar indica-leaning strains are proven in practice. CBD-dominant strains are particularly suitable for anxiety-related insomnia. CBN enrichment (e.g., through brief decarboxylation at low temperature) is described as helpful by some patients, but the scientific evidence remains limited.

## Summary

Cannabis can be an effective aid for certain sleep disorders but is not a universal sleeping pill. The evidence is strongest for short-term sleep onset assistance and for treating secondary insomnia from chronic pain or PTSD. Long-term daily use carries risks of tolerance development and rebound insomnia. Informed, moderate use – ideally under medical supervision – is the key to successful cannabinoid-based sleep therapy.